Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Change in Accured Expenses (2018 - 2025)

AdaptHealth has reported Change in Accured Expenses over the past 8 years, most recently at $27.5 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $27.5 million for Q4 2025, up 683.96% from a year ago — trailing twelve months through Dec 2025 was $139.3 million (up 311.66% YoY), and the annual figure for FY2025 was $139.3 million, up 311.66%.
  • Change in Accured Expenses for Q4 2025 was $27.5 million at AdaptHealth, down from $46.8 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AHCO hit a ceiling of $110.3 million in Q2 2024 and a floor of -$68.1 million in Q2 2023.
  • Median Change in Accured Expenses over the past 5 years was $4.0 million (2024), compared with a mean of $3.7 million.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 473.84% in 2021 and later surged 724.76% in 2022.
  • AdaptHealth's Change in Accured Expenses stood at -$1.5 million in 2021, then surged by 724.76% to $9.6 million in 2022, then skyrocketed by 576.79% to $64.7 million in 2023, then plummeted by 94.59% to $3.5 million in 2024, then skyrocketed by 683.96% to $27.5 million in 2025.
  • The last three reported values for Change in Accured Expenses were $27.5 million (Q4 2025), $46.8 million (Q3 2025), and $60.4 million (Q2 2025) per Business Quant data.